Pulmonary Arterial Hypertension In Systemic Sclerosis: Challenges In Diagnosis, Screening And Treatment
Didem Saygin,1 Robyn T Domsic2 1Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA; 2Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USACorrespondence: Robyn T DomsicDivision of Rheumatology and Clinical...
Guardado en:
Autores principales: | Saygin D, Domsic RT |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/86b5fef6ae60474eafe068dafbdf52b1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The role of TGF-β or BMPR2 signaling pathway-related miRNA in pulmonary arterial hypertension and systemic sclerosis
por: Bei Xu, et al.
Publicado: (2021) -
Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies
por: Tselios K, et al.
Publicado: (2016) -
Association between hypertension and osteoarthritis: A systematic review and meta-analysis of observational studies
por: Kenneth Lo, et al.
Publicado: (2022) -
Animal models of systemic sclerosis: their utility and limitations
por: Artlett CM
Publicado: (2014) -
Calcium pyrophosphate crystal deposition disease: diagnosis and treatment
por: Rosales-Alexander JL, et al.
Publicado: (2014)